0001437749-23-009270.txt : 20230404
0001437749-23-009270.hdr.sgml : 20230404
20230404160006
ACCESSION NUMBER: 0001437749-23-009270
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230307
FILED AS OF DATE: 20230404
DATE AS OF CHANGE: 20230404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Paula Molina Rene
CENTRAL INDEX KEY: 0001890868
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41058
FILM NUMBER: 23797143
MAIL ADDRESS:
STREET 1: C/O VAXXINITY, INC.
STREET 2: 1717 MAIN ST STE. 3388
CITY: DALLAS
STATE: TX
ZIP: 75201
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vaxxinity, Inc.
CENTRAL INDEX KEY: 0001851657
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 862083865
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 505 ODYSSEY WAY
CITY: EXPLORATION PARK
STATE: FL
ZIP: 32953
BUSINESS PHONE: (254) 244-5739
MAIL ADDRESS:
STREET 1: 505 ODYSSEY WAY
CITY: EXPLORATION PARK
STATE: FL
ZIP: 32953
4
1
rdgdoc.xml
FORM 4
X0407
4
2023-03-07
0001851657
Vaxxinity, Inc.
VAXX
0001890868
Paula Molina Rene
C/O VAXXINITY, INC.
505 ODYSSEY WAY
MERRITT ISLAND
FL
32953
1
See Remarks
0
Stock Option (right to buy)
2.29
2023-03-07
4
A
0
116612
0
A
2033-03-07
Class A Common Stock
116612
116612
D
The options were issued to the Reporting Person pursuant to the Issuer's 2021 Omnibus Incentive Compensation Plan. Such options vest in 48 equal monthly installments beginning on March 7, 2023.
General Counsel and Secretary.
/s/ Rene Paula Molina
2023-04-03